02 May 2003
Med Sci Monit 2003; 9(1): 70- :: ID: 15213
There is now good evidence that inhibitors of PARP activity reduce the tissue injury caused by regional myocardial ischemia and reperfusion. For instance, various, chemically distinct inhibitors of PARP activity [including 3-aminobenzamide (3-AB) and 1, 5-dihydroxyisoquinoline (ISO)] reduce the infarct size caused by ischaemia-reperfusion injury of the rabbit heart in vivo. In addition, 3-AB and ISO also reduce the infarct size caused by regional myocardial ischaemia and reperfusion in the heart of the rat in vivo and in vitro. Moreover, ISO reduces the contractile dysfunction, the fall in high-energy phosphates caused by global myocardial ischemia and reperfusion in the rat heart. Exposure of human cardiac myoblasts in vitro results in an increase in PARP activity, and secondary cell death. Inhibition of this increase in PARP activity reduces the impairment in mitochondrial respiration as well as the associated cell death caused by these reactive oxygen species. The tissue injury caused by coronary artery occlusion and reperfusion in PARP-1 knock out mice is substantially reduced (when compared to their wild-type litter mates). Potent, water-soluble inhibitors of PARP activity (including 5-aminoisoquinolinone, PJ-34 and others) cause a substantial reduction in myocardial infarct size in the rat in vivo. Taken together, these findings support the view that (1) the excessive activation of PARP contributes to myocardial reperfusion injury, and (2) potent, water-soluble inhibitors of PARP activity may be useful in conditions associated with acute myocardial ischemia and reperfusion. These conditions may include acute myocardial infarction, coronary angioplasty, cardiac transplantation and bypass heart surgery. References: 1.Thiemermann C et al: Proc Natl Acad Sci USA, 1997; 94: 679-683
Keywords: Heart, Infarction, 5-AIQ, Reperfusion Injury, cardiac ischemia, ischaemia
01 May 2022 : EditorialEditorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19
Med Sci Monit 2022; 28:e937048
04 May 2022 : Clinical ResearchEffects of Wearing Face Masks on Exercise Capacity and Ventilatory Anaerobic Threshold in Healthy Subjects ...
Med Sci Monit In Press; DOI: 10.12659/MSM.936069
27 May 2022 : Clinical ResearchFactors Associated with Falls During Hospitalization for Coronavirus Disease 2019 (COVID-19)
Med Sci Monit 2022; 28:e936547
25 May 2022 : Review articleNarrative Review of the Mechanism of Hip Prosthesis Dislocation and Methods to Reduce the Risk of Dislocation
Med Sci Monit In Press; DOI: 10.12659/MSM.935665
24 May 2022 : Clinical ResearchRemimazolam Tosilate Sedation with Adjuvant Sufentanil in Chinese Patients with Liver Cirrhosis Undergoing ...
Med Sci Monit In Press; DOI: 10.12659/MSM.936580
Most Viewed Current Articles
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996